Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent method reduces cost and safety risks for abemaciclib intermediate manufacturing ensuring reliable supply chain continuity.
Novel Pictet-Spengler route from furfural reduces cost and complexity for pharmaceutical intermediates manufacturing.
Novel biocatalytic route for (R)-1-(4-bromophenyl)-2,2,2-trifluoroethanol using Cyberlindnera saturnus. High ee, mild conditions, scalable pharma intermediate production.
Patent CN108383880A reveals novel coumarin-platinum complexes targeting ovarian cancer resistance. Offers high purity and scalable synthesis for pharmaceutical supply chains.
Patent CN113462728A details a novel whole-cell biocatalytic route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113583088A details novel cyclic peptide synthesis targeting STRN3 for gastric cancer, offering improved stability and cell permeability for pharmaceutical manufacturing.
Patent CN112048538B reveals a high-yield biocatalytic route for Aprepitant intermediates using Cyberlindnera saturns, offering superior purity and cost efficiency.
Patent CN103224481A details a high-yield Dehydroequol process using Daidzein. This method offers significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel CuI-catalyzed route for Cyanogramide skeleton. High yield, mild conditions, scalable for pharmaceutical intermediates supply chain efficiency.
Novel patent method ensures high purity brivaracetam impurity standard. Cost-effective scalable route for pharmaceutical intermediates manufacturing.
Advanced synthesis of Hydrocortisone Butyrate via selective acylation. Reliable supplier offering cost-effective pharmaceutical intermediates with stringent quality control.
Novel enzymatic resolution process ensures high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains globally. This patent offers significant advantages.
Novel patent CN108752184A offers eco-friendly SGLT2 intermediate synthesis. Reduces cost and waste. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN104610226A reveals a novel asymmetric oxidation method for dexlansoprazole intermediates, offering high purity and scalable supply chain advantages for global pharmaceutical manufacturers.
Novel late-stage deuteration route for Lumefantrine-D9 via patent CN111320547B. Cost-effective alternative to di-n-butylamine-D9 for high-purity pharmaceutical intermediate manufacturing.
Advanced ethanol recrystallization patent CN101337907B ensures high purity contrast agent intermediates with optimized supply chain efficiency and cost effectiveness.
Patent CN119019478B reveals novel glycosylation method for Type II Lipoteichoic Acid. Enables scalable production and cost reduction for pharmaceutical intermediates.
Patent CN119019478A reveals a novel glycosylation method for Type II lipoteichoic acid, offering high conversion and scalable manufacturing for immunological research.
Patent CN116969889B reveals photocatalytic method for phenanthridines offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101547890A details a catalytic asymmetric synthesis of primary amines using spiroboronic esters, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.